Subsequent experiments, including protein blotting and RT-qPCR analysis, confirmed the activation of the IL-17 signaling pathway by HPMHD in the COPD mouse model, further supporting the initial findings. This evidence concerns the gene IL17A and chronic obstructive pulmonary disease.